share_log

Piper Sandler Maintains Neutral on Humacyte, Maintains $4 Price Target

Moomoo 24/7 ·  Mar 26 08:26

Piper Sandler analyst Allison Bratzel maintains Humacyte (NASDAQ:HUMA) with a Neutral and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment